Related Experiment Video
Updated: Jun 29, 2025

Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
Development of Losartan Orally Disintegrating Tablets by Direct Compression: a Cost-Effective Approach to Improve
Candela Juan1,2, Loreana Gallo1,3, Noelia Gonzalez Vidal4,5
1Departamento de Biología, Bioquímica y Farmacia-Universidad Nacional del Sur (UNS), Bahía Blanca, Buenos Aires, Argentina.
Insights
This study developed orally disintegrating tablets (ODTs) for pediatric arterial hypertension treatment using losartan potassium. The ODTs demonstrated rapid drug release and stability, offering a promising new dosage form for children.
Area of Science:
- Pharmacology
- Pharmaceutical Technology
- Pediatric Medicine
Background:
- Effective pharmacological treatment in children requires suitable dosage forms.
- Orally disintegrating tablets (ODTs) offer advantages like ease of administration and dosage accuracy, particularly for pediatric patients.
- Arterial hypertension in children necessitates specialized and accessible treatment options.
Purpose of the Study:
- To develop and characterize orally disintegrating tablets (ODTs) containing losartan potassium (LP) for treating arterial hypertension in children.
- To evaluate the impact of various superdisintegrants and diluents on ODT properties.
- To assess the in vitro performance and preliminary stability of the developed ODTs.
Main Methods:
- Losartan potassium ODTs were formulated using direct compression with different superdisintegrants and diluents.
- Thirty formulations were evaluated for disintegration time, hardness, and friability.
- Drug-excipient compatibility, tabletability, flow properties, in vitro dissolution, and preliminary stability were assessed.
Main Results:
- Two formulations met optimal criteria for disintegration time (<30 s), hardness, and friability (≤1.0%).
- Developed ODTs exhibited favorable drug-excipient compatibility, tabletability, and flow characteristics.
- In vitro dissolution studies showed very rapid drug release, and stability studies indicated the need for protective packaging, with retained quality after 12 months in airtight containers.
Conclusions:
- Successfully developed and characterized losartan potassium ODTs suitable for pediatric use.
- The ODTs represent a potential advancement in the treatment of childhood arterial hypertension.
- Further development into a final prototype is warranted to improve pediatric hypertension management.
Abstract:
The development of suitable dosage forms is essential for an effective pharmacological treatment in children. Orally disintegrating tablets (ODTs) are attractive dosage forms that avoid swallowing problems, ensure dosage accuracy and are easy to administer as they disintegrate in the oral cavity. This study aimed to develop ODTs containing losartan potassium (LP) for the treatment of arterial hypertension in children. The ODTs, produced by the cost-effective manufacturing process of direct compression, consisted of a mixture of diluent, superdisintegrant, glidant and lubricant. Five superdisintegrants (croscarmellose sodium, two grades of crospovidone, sodium starch glycolate and pregelatinized starch) were tested (at two concentrations), and combined with three diluents (mannitol, lactose and sorbitol). Thus, thirty formulations were evaluated based on disintegration time, hardness and friability. Two formulations, exhibiting the best results concerning disintegration time (< 30 s), hardness and friability (≤ 1.0%), were selected as the most promising ones for further evaluation. These ODTs presented favourable drug-excipient compatibility, tabletability and flow properties. The in vitro dissolution studies demonstrated 'very rapid' drug release. Preliminary stability studies highlighted the requirement of a protective packaging. All quality properties retained appropriate results after 12 months of storage in airtight containers. In conclusion, the ODTs were successfully developed and characterised, suggesting a potential means to accomplish a final prototype that enables an improvement in childhood arterial hypertension treatment.
More Related Videos
04:28Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
04:22Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
Published on: March 30, 2017
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Drug Delivery: Enteral Route
Antihypertensive Drugs: Direct Renin Inhibitors
Routes of Drug Administration: Enteral
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers